01. Who We Are & Who Compiles This Library
Her Metabolic Health (hermetabolichealth.com) is an independent patient research publication and self-advocacy tool library founded by Cat Clark, author of FAT BITCH: Killing the Willpower Myth and FAT BITCH: The Anti-Diet Workbook (ISBN 979-8-9948878-8-2). The library is published by UNLIT Publishing (unLit Publishing LLC, 3721 W Michigan Ave, Suite 100, PMB 178, Lansing, MI 48917), with core methodological intellectual property held by Tumble and Sluice LLC.
We built Her Metabolic Health to solve a structural gap in modern metabolic care: when direct-to-consumer telehealth and 15-minute primary care visits shortened appointment times, patients were left managing 100% of day-to-day GLP-1 titration questions, gastrointestinal shifts, lean-muscle preservation, and prior authorization appeals without access to the underlying primary literature. Our editorial research team compiles peer-reviewed endocrine, neurobiological, and pharmacokinetic research into plain-language guides and interactive worksheets so patients and their clinicians can work from the same published evidence.
02. Why We State Plainly That No Clinician Reviews Our Content
Many commercial health websites attach a rented physician head-shot and a "Medically Reviewed By" badge to marketing copy written to sell a subscription box. We do the opposite:
- No Clinician on Staff: Her Metabolic Health is a patient research organization. Neither Cat Clark nor the UNLIT Publishing editorial research team holds a medical license, and no physician, nurse practitioner, or pharmacist reviews our pages prior to publication.
- Primary Citations Instead of Authority Badges: Rather than asking readers or clinicians to trust an unverified "medical review" stamp, every mechanism, dosing table, and calculator threshold on this site links directly to its underlying PubMed identifier (PMID), randomized controlled trial, or FDA package insert so any reader or prescriber can verify the primary data in seconds.
- Last Updated (Compilation Date) vs. Clinical Review: Every page footer and schema record reports when the research compilation was last updated and audited against primary literature, never a clinical review date.
03. Primary Source Hierarchy & Research Compilation Methodology
Every biological guide in The Shared Agency Framework (SAF), every calculator in the Patient Tools Vault, and every reference module in the Clinician Portal (/clinicians/) is compiled strictly from four primary source tiers:
| Evidence Tier | Eligible Primary Sources | Canonical Examples Used Across HMH |
|---|---|---|
| Tier 1: FDA Labels & Regulatory Communications | Official U.S. Food and Drug Administration (FDA) Prescribing Information, Medication Guides, and Drug Safety Communications. | Wegovy, Ozempic, Zepbound, and Mounjaro FDA Package Inserts (titration schedules, missed-dose rules, tirzepatide oral contraceptive Cmax/AUC interaction); FDA Jan 13, 2026 GLP-1 Labeling Update; Section 503A & 503B FD&C Act compounding rules. |
| Tier 2: Phase 3 Randomized Controlled Trials (RCTs) | Peer-reviewed multi-center randomized clinical trials published in NEJM, JAMA, and The Lancet. | STEP 1 (PMID: 33567185, including the DXA body-composition substudy showing ~39% of total weight lost as lean mass); SURMOUNT-1 (PMID: 35658024); SURMOUNT-4 (PMID: 38078870); SELECT CV outcomes (PMID: 37952131). |
| Tier 3: Consensus Clinical Guidelines & Commissions | Multi-society clinical practice guidelines, consensus position papers, and international commissions. | PROT-AGE Study Group protein targets (PMID: 23849196); Lancet Diabetes & Endocrinology Commission on Clinical Obesity (PMID: 39824205); ASA/AGA/ASMBS multi-society perioperative GLP-1 guidance. |
| Tier 4: Mechanistic Human & Preclinical Studies | Peer-reviewed human physiological/fMRI studies and clearly labeled preclinical animal receptor studies. | Human set-point hormone persistence (Sumithran et al., PMID: 22029981); human fMRI BOLD food-cue reactivity (van Bloemendaal et al., PMID: 25071023); rodent VTA/NAc GLP-1R studies (Dickson et al., PMID: 22492036; Anderberg et al., PMID: 23867619). |
Human vs. Preclinical Labeling Rule: Whenever a neurobiological mechanism (such as direct GLP-1 receptor binding in the ventral tegmental area or nucleus accumbens) comes from rodent preclinical models rather than human tissue studies, our editorial policy requires stating explicitly which findings are preclinical animal data and which are human fMRI or clinical trial results.
04. The 100-Point Provider Directory Grading Rubric & Affiliate Independence
Our 50-state Find A Provider Directory and Provider Directory Accreditation Rubric evaluate obesity medicine, endocrinology, direct primary care, and telehealth practices on a published 100-point scale:
- Minimum 70-Point Recommended Standard: Practices must score at least 70 out of 100 across clinician credential verification, transparent all-in pricing before checkout, individualized titration, lean-mass and lab monitoring, and weight-inclusive care.
- Automatic Gate-Fail Rules (GS-1 to GS-5): Any provider that promises a specific weight-loss number (GS-1), forces proprietary supplement bundles to obtain a prescription (GS-2), sells unregulated research peptides (GS-3), uses shame-based marketing (GS-4), or hides recurring membership fees (GS-5) fails automatically regardless of point total.
- Strict Separation of Scoring & Referral Fees: Some Recommended providers pay a referral fee if a visitor signs up through an active partner link. Referral fees never alter a provider's score, tier, or display order, and providers that fail our 70-point standard are published in our Reviewed and Not Recommended section with their reason codes and with contact links withheld.
- Pre-Launch Care Model Blueprint (Our Program & Waitlist): We also publish a design blueprint and state-by-state interest waitlist for a potential future care model pairing independent licensed prescribers with the Shared Agency Framework. No clinical partner, pharmacy, or EMR is under contract today, and joining the waitlist on get-started.html is 100% free with zero billing.
05. Corrections Policy, Audit Log & Copyright Terms
We audit every citation, PubMed ID (PMID), trial percentage, and calculator formula on a rolling basis. When an error or imprecise citation is identified, we correct the live HTML and printable PDFs, verify every PMID against the National Library of Medicine (PubMed), and record the change. On October 27, 2026, we completed a full citation audit correcting eight PMIDs across the library, clarifying preclinical VTA/NAc vs. human fMRI dopamine evidence, updating STEP 1 DXA lean-mass proportion language (25% to 39%), and softening protein intake guidance (1.2 to 1.6 g/kg) to an evidence-informed suggested target adjusted with a clinician for renal status.
Sharing & Copyright Policy: All guides, clinician desk references, and printable PDF worksheets on Her Metabolic Health are copyright © 2026 Tumble and Sluice LLC and published by unLit Publishing LLC. Materials may be downloaded, printed, and shared by patients and clinicians with full attribution to Her Metabolic Health (hermetabolichealth.com) and no modifications. All rights reserved. To report a citation error or request a correction, email [email protected].